Diabetes Care and CamDiab are pleased to announce that Health Canada has approved the use of mylife Loop powered by mylife ...

The monitors were giving incorrect, low readings.

Abbott, the creator of continuous glucose monitors, launched the new Assist feature at CES 2026. Part of the Libre app, it aims to help people with diabetes take the guesswork out of how food affects ...

Boone Health said Abbott has been assisting with the redistribution of new monitors Freestyle Libre 3 and 3 Plus since recall.

Libre Assist 1 uses generative AI to predict how a food choice may affect a person's glucose levels. 2 It then offers actionable and personalized meal guidance 3 to support in-the-moment decisions.

Abbott Laboratories (NYSE: ABT) doesn’t just pay dividends. It grows them. For 52 consecutive years. That’s Dividend King ...

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...

'It was a miracle I was diagnosed to begin with.' ...

Insulin delivery options for people living with type 1 diabetes have developed rapidly in recent years. However, even though semi-automatic pumps reduce the risk of complications and simplify patients ...

A new breath-based sensor, currently in human trials, could potentially enable the Apple Watch to non-invasively monitor blood sugar levels.

Kilkenny Live reports that Abbott (NYSE:ABT) is seeking permission to expand its facility in Kilkenny, Ireland.

'It was a miracle I was diagnosed to begin with.' ...